Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038379 (
strabismus
)
9,317
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study evaluates functional vision in visually impaired children with stage IV to V cicatricial
retinopathy of prematurity
(CROP) by comparing results derived from the Teller acuity cards and a battery of behavioral tasks, the visual function battery (VFB). Vision was evaluated in 26 eyes of 15 children ages 6 months to 14 years, who underwent retinal reattachment procedures for active stage IV and stage V
retinopathy of prematurity
. Results showed that 10 of 26 eyes (38%) had a recordable grating acuity to Teller acuity card assessment. Twenty-five of 26 eyes (96%) showed a response to the VFB. Sixteen of 26 eyes (62%) showed recordable scores with the VFB but no corresponding scores with the Teller acuity cards. The VFB may be more reliable than the Teller acuity cards in measuring visual function in the very low acuity range.
J Pediatr Ophthalmol
Strabismus
PMID:Measurement of low vision in advanced cicatricial retinopathy of prematurity. 763 1
The visual function of some children with structural defects of the macula or optic nerve has previously been shown to improve with occlusion therapy. The charts of five children, ages 4 to 8 years, who had various types of severe structural abnormalities were reviewed. Two patients had optic nerve hypoplasia; there was one case each of foveal hypoplasia, posterior persistent hyperplastic primary vitreous, and
retinopathy of prematurity
. All the patients had undergone extensive amblyopia therapy prior to referral. In three children, occlusion therapy had been initiated and continued intensively for several months or longer without recognizing the presence of a severe, underlying structural abnormality. In none of the five children was there any clear-cut evidence of visual improvement. In some cases, the long period of enforced iatrogenic vision impairment resulted in significant psychosocial harm and developmental delay. In all five cases, it was structural changes rather than amblyopia that ultimately accounted for visual loss. The authors stress the importance of a meticulous fundus examination directed at finding organic defects prior to patching. Close, periodic monitoring of visual function should then follow. To spare the child unnecessary psychosocial impairment, it is advisable to follow established recommended thresholds for terminating occlusion therapy.
J Pediatr Ophthalmol
Strabismus
PMID:Reappraisal of occlusion therapy for severe structural abnormalities of the optic disc and macula. 775 32
More and more authors point out the existence of the retinal folds at the prematures with
retrolental fibroplasia
. This form is considered to be achieved. The survey has been done during 3 years on 27 children, divided in 2 groups: the former was the group of the prematures with retinal fold present in
retrolental fibroplasia
, and the later was the group of children with congenital retinal fold, but born at time. Clinically, the difference between the two types of folds is not so obvious, but from the morphoscopical aspect they differ. The therapy of the diagnosed children was the usual one done in complications:
strabismus
, cataract, retinal detachment. The conclusions is that, besides the malformative retinal fold of the child born at time, another similar lesion provoked by the prematurity and abusive oxygenation is possible.
...
PMID:[The retinal fold in premature infants]. 776 80
We reviewed the results of three randomized clinical trials of prophylactic bovine surfactant therapy on babies under 30 weeks gestational age to assess the effects of this treatment on the frequency and severity of
retinopathy of prematurity
(
ROP
). Of the 119 babies who received surfactant treatment, 54 (45.4%) had
ROP
compared to 33 (47.1%) of the 70 babies in the control group. Stage 2
ROP
or greater was noted in 10 (8.4%) babies in the treatment group and in 10 (14.3%) of the untreated group. Prophylactic bovine surfactant replacement therapy does not have a significant effect on the frequency of
ROP
in preterm babies. The severity of
ROP
also appears to be unaffected by surfactant.
J Pediatr Ophthalmol
Strabismus
PMID:Bovine surfactant therapy and retinopathy of prematurity. 780
A new scleral depressor has been designed that enables easy insertion into a small conjunctival sac, facilitating examination of the ocular fundus in extremely premature infants with
retinopathy of prematurity
. This new scleral depressor is also useful in mature infants and children.
J Pediatr Ophthalmol
Strabismus
PMID:A new scleral depressor for extremely premature infants. 780 7
Retinopathy of prematurity
is a common disorder among extremely low-birthweight preterm infants and may cause total vision loss in as many as 2% to 4% of those weighing less than 2 pounds at birth. Regular examinations begun in the neonatal intensive care unit permit early detection and treatment of progressive
ROP
and allow a reduction in visual impairment. Infants whose
ROP
has regressed should continue to receive regular ophthalmologic follow-up for the detection and treatment of myopia and
strabismus
and, if they have cicatricial sequelae, late retinal detachments as teens or adults. Early intervention and special education programs are important for the children whose vision loss is significant.
...
PMID:Retinopathy of prematurity. 787 10
Prophylactic lung surfactant is commonly used to reduce the severity of neonatal respiratory distress syndrome in premature infants. There is disagreement in the literature regarding the effect of prophylactic lung surfactant on the incidence of
retinopathy of prematurity
(
ROP
). Sixty-four infants, gestational age 23 to 32 weeks, birth weight 610 to 1250 g, were randomized to receive either intratracheal bovine surfactant prophylaxis or air control, at our institution, as part of a national double-masked multicenter trial. Forty-eight of these infants survived and underwent complete ophthalmologic examinations by a single masked examiner.
ROP
data were gathered retrospectively.
ROP
developed in 19 of the 23 (83%) who received surfactant and 15 of the 25 (60%) controls (P = .1). Analysis of the worst stage of
ROP
for each infant also revealed no difference between the surfactant and control groups (P = .4). Our retrospective analysis of
ROP
data in a prospective double-masked randomized study revealed no significant effect of surfactant on the incidence or severity of
ROP
.
J Pediatr Ophthalmol
Strabismus
PMID:Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity. 793 53
Threshold
retinopathy of prematurity
occurred in 11 of 34 Alaskan natives compared with 10 of 93 non-natives. Natives constitute 16% of the state population. This significant Alaskan native preponderance was not explained by differences in prenatal or intensive care unit morbidity except that the intervals from birth to extubation and birth to cryotherapy were shorter for natives.
J Pediatr Ophthalmol
Strabismus
PMID:Susceptibility to retinopathy of prematurity in Alaskan Natives. 793 54
We characterized the regression pattern of
retinopathy of prematurity
(
ROP
) for 266 infants examined over a 22-month period. Infants were included in the evaluation with a birth weight of less than or equal to 1500 g. Regression of retinopathy was observed in all but 11 infants, who were treated for threshold
ROP
.
ROP
limited to the peripheral retina resolved around term (40 weeks postconceptional age). Posterior
ROP
and/or stage 3
ROP
underwent a protracted course of resolution, often not reaching zone 3 until 42 to 45 weeks after conception. Permanent retinal/vascular sequelae of
ROP
were observed in 10% of infants with
ROP
. The most common abnormality was failure to completely vascularize the temporal retinal periphery. Overall, retinal morbidity from
ROP
was an infrequent occurrence (18 of 266 premature infants--6.8%).
J Pediatr Ophthalmol
Strabismus
PMID:Regression pattern in retinopathy of prematurity. 793 51
We wanted to investigate the value of using a lid speculum and scleral indentation in performing binocular indirect ophthalmoscopy (BIO) in neonates at risk of
retinopathy of prematurity
(
ROP
). We performed a prospective masked comparison of BIO examinations using either a lid speculum and scleral indentation (SI) or no scleral indentation (NSI), in our neonatal intensive care unit. We did 57 consecutive BIO examinations of infants weighing less than 1500 g and/or having a gestational age of less than 32 weeks. With NSI, zone I
ROP
was reliably seen in 53 of 57 examinations; the superior, nasal, and temporal aspects of zone II were seen in 45 of 57 examinations; inferior zone II, in 22 of 57 examinations; and zone III in 1 of 57 examinations. SI facilitated complete peripheral fundus examination in all cases but had to be abandoned in two infants due to acute changes in oxygen saturation levels. Five infants developed threshold disease, and in two of them details of the active
ROP
ridge were missed with NSI. The gentle use of an eyelid speculum and globe rotation allows rapid and relatively atraumatic assessment of the peripheral fundus, even in babies who are being ventilated. Although threshold
ROP
may be diagnosed by observation of posterior retinal vessel dilation and tortuosity ("plus" disease), accurate grading of
ROP
is likely to require SI. In the absence of clearly developed "plus" disease, borderline or prethreshold disease may occasionally be missed using BIO with NSI. SI is necessary to examine the inferior midperipheral retinal vasculature (zone II) and the far peripheral temporal retina (zone III) and is associated with few complications.(ABSTRACT TRUNCATED AT 250 WORDS)
J Pediatr Ophthalmol
Strabismus
PMID:Screening for retinopathy of prematurity: are a lid speculum and scleral indentation necessary? 812 Jul 43
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>